These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Frequency of circulating topoisomerase-I-specific CD4 T cells predicts presence and progression of interstitial lung disease in scleroderma. Fava A; Cimbro R; Wigley FM; Liu QR; Rosen A; Boin F Arthritis Res Ther; 2016 May; 18(1):99. PubMed ID: 27145754 [TBL] [Abstract][Full Text] [Related]
4. Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis. Wortel CM; Liem SI; van Leeuwen NM; Boonstra M; Fehres CM; Stöger L; Huizinga TW; Toes RE; De Vries-Bouwstra J; Scherer HU RMD Open; 2023 Jul; 9(3):. PubMed ID: 37507206 [TBL] [Abstract][Full Text] [Related]
5. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry. Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J; Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608 [TBL] [Abstract][Full Text] [Related]
6. Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti-topoisomerase I-positive systemic sclerosis-associated interstitial lung disease. Ebata S; Yoshizaki A; Fukasawa T; Miura S; Takahashi T; Sumida H; Asano Y; Sato S J Dermatol; 2019 Nov; 46(11):1006-1013. PubMed ID: 31502326 [TBL] [Abstract][Full Text] [Related]
8. Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis-an exploratory study. Hamberg V; Sohrabian A; Volkmann ER; Wildt M; Löfdahl A; Wuttge DM; Hesselstrand R; Dellgren G; Westergren-Thorsson G; Rönnelid J; Andréasson K Arthritis Res Ther; 2023 Sep; 25(1):162. PubMed ID: 37667402 [TBL] [Abstract][Full Text] [Related]
9. Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as potential makers for digital ulcers and interstitial lung disease in patients with systemic sclerosis: cross-sectional analysis of data from a prospective cohort study. Kim A; Kim Y; Kim GT; Ahn E; So MW; Sohn DH; Lee SG Rheumatol Int; 2020 Jul; 40(7):1071-1079. PubMed ID: 32424613 [TBL] [Abstract][Full Text] [Related]
10. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease. Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320 [TBL] [Abstract][Full Text] [Related]